|
|
ABO blood group does not influence Child‐Pugh A cirrhosis outcome: An observational study from CIRRAL and ANRS CO12 CIRVIR cohorts
Isabelle Ollivier-Hourmand
,
Yohann Repesse
,
Pierre Nahon
,
Cendrine Chaffaut
,
Thông Dao
,
et al.
Article dans une revue
hal-03553907v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Sofosbuvir plus Velpatasvir plus Voxilaprevir in Daa Failure Patients with Cirrhosis. Final Results of the French Compassionate Use Program
Christophe Hezode
,
Dominique Guyader
,
Eric Nguyen-Khac
,
Dominique Larrey
,
Regine Truchi
,
et al.
Hepatology, 2018, 68 (1), pp.374A
Article dans une revue
hal-03590862v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Extrahepatic cancers are the leading cause of death in patients achieving hepatitis B virus control or hepatitis C virus eradication
Manon Allaire
,
Pierre Nahon
,
Richard Layese
,
Valérie Bourcier
,
Carole Cagnot
,
et al.
Article dans une revue
hal-02648452v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Sofosbuvir plus velpatasvir plus voxilaprevir in DAA failure patients with cirrhosis: Final results of the French compassionate use program
Christophe Hezode
,
Dominique Guyader
,
Eric Nguyen-Khac
,
Dominique Larrey
,
Regine Truchi
,
et al.
Article dans une revue
hal-03590860v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Large-scale screening of lipase acid deficiency in at risk population
Abdellah Tebani
,
Bénédicte Sudrié-Arnaud
,
Hela Boudabous
,
Anais Brassier
,
Rodolphe Anty
,
et al.
Article dans une revue
hal-03223991v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Prevalence and Incidence of Subclinical Proximal Tubulopathy (SPT) over 96 Weeks in Chronic Hepatitis B (CHB) Patients Treated with Entecavir (ETV) or Tenofovir Disoproxil (TDF) without Renal Insufficiency (RI) or Hypophosphatemia during the Follow-up
Anais Brayette
,
Marie Essig
,
Paul Carrier
,
Marilyne Debette-Gratien
,
Anais Labrunie
,
et al.
The AASLD Liver Meeting 2018, Nov 2018, San Francisco, United States. , Hepatology, 68 (S1), pp.247A-248A
Poster de conférence
hal-02003052v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Efficacy and safety of elbasvir/grazoprevir for 8 or 12 weeks for hepatitis C virus genotype 4 infection: A randomized study
Tarik Asselah
,
Stanislas Pol
,
Christophe Hezode
,
Veronique Loustaud-Ratti
,
Vincent Leroy
,
et al.
Article dans une revue
hal-03590858v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
In vitro infection of primary human hepatocytes by HCV-positive sera: insights on a highly relevant model
Claire Gondeau
,
Philippe Briolotti
,
Francia Razafy
,
Cédric Duret
,
Pierre-Alain Rubbo
,
et al.
Article dans une revue
hal-03082070v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Subclinical proximal tubulopathy in hepatitis B: The roles of nucleot(s)ide analogue treatment and the hepatitis B virus
Paul Carrier
,
Marilyne Debette-Gratien
,
Anais Labrunie
,
Sophie Alain
,
Marianne Maynard
,
et al.
Article dans une revue
hal-03590856v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Efficacy and Safety of Elbasvir/Grazoprevir for 8 or 12 Weeks in Participants with Hepatitis C Virus Genotype 4 Infection
Tarik Asselah
,
Stanislas Pol
,
Christophe Hezode
,
Veronique Loustaud Ratti
,
Vincent Leroy
,
et al.
Hepatology, 2018, 68 (1), pp.385A
Article dans une revue
hal-03590861v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|